微小RNA-145对于HepG2细胞侵袭能力的影响
被引量:2
摘要
近10年来,大量研究表明微小RNA(miRNA)参与了肿瘤的形成和演进。研究者发现肝癌中microRNAs表达与配对正常组织明显差异。目前尚不知miR-145在肝癌中表达情况及其功能,本研究旨在探讨miR-145在肝癌中的表达和功能,并分析其作用机制。
出处
《中华实验外科杂志》
CAS
CSCD
北大核心
2011年第12期2249-2249,共1页
Chinese Journal of Experimental Surgery
基金
基金项目:上海市科委基金项目(STCSM10411964700)
参考文献10
-
1Sonia AM, Manel E. Dysregulation of mi- cmRNAs in cancer: Playing with fire. FEBS Lett ,2010,585:2087-2099.
-
2Dillhoff M, Wojcik SE, Bloomston M. Mi- croRNAs in solid tumors. J Surg Res, 2009,154:349-354.
-
3Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA ex- pression patterns in hepatoceUular carci- noma and non-tumorous tissues. Onco- gene ,2006,25:2537-2545.
-
4Meng FY, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in hu- man hepatocellular cancer. Castroenterolo- gy ,2007,133:647-658.
-
5Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res, 2005,33:179.
-
6Livak K J, Schmittgen TD. Analysis of rela- tive gene expression data using Real-time quantitative PCR and the 2^-△△ct meth- od. Methods,2001,25:402-408.
-
7Gotte M, Mohr C, Koo CY, et al. miR-145- dependent targeting of junctional adhesion molecule A and modulation of fascin ex- pression are associated with reduced breast cancer cell motility and invasive- ness. Oncogene,2010,29:6569-6580.
-
8Zhang JJ, Guo HY, Zhang H, et al. puta- tive tumor suppressor miR-145 inhibits colon cancer cell growth by targeting onco- gene friend leukemia virus integration 1 gene. Cancer,2011,11:86-95.
-
9Spizzo R, Nicoloso MS, Lupini L, et al. MiR-145 participates with TP53 in a death-promoting regulatory loop and tar- gets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ, 2010,17:246-254.
-
10Hayashi Y, Osanai M, Lee GH. Fasein-1 expression correlates With repression of E- cadherin expression in hepatocellular car- cinoma cells and augments their invasive- hess in combination with matrix metallo- proteinases. Cancer Sci, 2011, 102 : 1228- 1235.
同被引文献13
-
1Braconi C, Patel T. MicroRNA expression profiling:A molecular tool for defining the phenotype of hepatocellular tumors. Hepatology, 2008,47 : 1807-1809.
-
2Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA profiling in hepa- tocellular tumors is associated with clinical features and oncogene/ tumor suppressor gene mutations. Hepatology, 2008,47 : 1955-1963.
-
3Mott JL. MicroRNAs involved in tumor suppressor and oneogene path- ways : implications for hepatobifiary neoplasia. Hepatology, 2009,50 : 630-637.
-
4Chan E, Patel R, Nallur S, et al. MicroRNA signatures differentiate melanoma subtypes. Cell Cycle ,2011,10 : 1845-1852.
-
5Chien WW, Domenech C, Catallo R, et al. Cyclin-dependent kinase-1 expression is inhibited by p16(INK4a) at the posttranscriptional level through the microRNA pathway. Oncogene,2011,30:1880-1891.
-
6Zhang X,Zhu W,Zhang J, et al. MicroRNA-650 targets INCA- to pro- mote gastric cancer tumorigenicity. Biochem Biophys Res Commun, 2010,395:275-280.
-
7Russell M, Berardi P, Gong W, et al. Grow-ING, Age-ING and Die- ING:ING proteins link cancer, senescence and apoptosis. Exp Cell Res ,2006,312:951-961.
-
8Li M, Jin Y, Sun WJ, et al. Reduced expression and novel splice va- riants of ING4 in human gastric adenocarcinoma. J Patho1,2009,219 : 87-95.
-
9Fang F, Luo LB, Tao YM, et al. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prey,2009,18:409-416.
-
10Huang S, He X. The role of microRNAs in liver cancer progression. Br J Cancer,2011 ,'104:235-240.
二级引证文献4
-
1徐学虎,吴小兵,伍尚标,孙嫣,刘海波,陈戎.微小RNA-193b在结直肠癌中的表达[J].中华实验外科杂志,2015,32(4):695-697. 被引量:2
-
2郭海燕,王红钰,李晓英,孙琪,李玉红.青蒿素对线粒体损伤诱导的乳腺癌细胞凋亡的影响[J].中国临床药理学杂志,2022,38(6):508-512. 被引量:2
-
3沈蓉,陈淼.乳腺癌组织中环状RNA CDR1as及miR-483-5p表达特点及临床意义[J].中国现代医药杂志,2023,25(1):47-50.
-
4雷洁琼,田迎霞,李正果,王兴东.葡萄籽提取物原花青素通过LncRNA NBR2/miR-650调节EMT抑制肝癌细胞Hep3B增殖、迁移和侵袭的分子机制[J].中国老年学杂志,2023,43(17):4307-4312. 被引量:3
-
1孙厚良,梅学英,付春玲,江秀娟,王玎.宫颈癌患者癌组织miR-145表达及意义[J].山东医药,2017,57(12):61-62. 被引量:2
-
2马金阳,陈谦学.微小RNA-145在胶质瘤中的表达及其临床意义[J].中华实验外科杂志,2014,31(9):1871-1873. 被引量:5
-
3窦越,王薇,唐勇.miR-145在胃癌中的表达及其意义[J].世界华人消化杂志,2015,23(35):5683-5687. 被引量:1
-
4杨丹.肝细胞肝癌患者血清微小RNA-145水平的研究[J].中华实验外科杂志,2016,33(5):1420-1420.
-
5施天培,王勇,胡俊,李娟,孙跃明.miR-145对结肠癌细胞HCT116增殖、侵袭和迁移能力的影响[J].江苏医药,2014,40(23):2828-2830. 被引量:5
-
6胡臻,李佳,房林.miR-145在肝癌中的表达和功能研究[J].同济大学学报(医学版),2012,33(2):43-46. 被引量:2
-
7徐磊,蒋峰,杨欣,笪良山,钱亦淳,王洁,尹荣,许林.非小细胞肺癌组织微小RNA-145表达及其与预后的关系[J].中华实验外科杂志,2014,31(1):177-179. 被引量:10
-
8王佳辰,司亚卿,秦贯军.肝癌细胞DNA甲基转移酶3b通过微小RNA-145调节细胞周期素D1基因表达的研究[J].中华实验外科杂志,2014,31(8):1715-1717. 被引量:2
-
9夏文杰,游庆军,王洁,毛启星,董高超,许林,蒋峰.DNA甲基化调控肺腺癌微小RNA-145表达的分子机制[J].中华实验外科杂志,2015,32(5):1078-1080. 被引量:3
-
10黄远帅,周炜鑫,罗彬瑞,郭天虹.循环miR-145和miR-484在乳腺癌诊断中的研究[J].检验医学与临床,2015,12(24):3623-3625. 被引量:2